B O O K - American College of Rheumatology

B308
Inflammatory Eye Disease P/C
Moderator: Sandra J. Watcher, BSN; Children’s Hospital of Los
Angeles; Los Angeles, CA
Speakers: Andreas O. Reiff, MD; Children’s Hospital of Los
Angeles; Los Angeles, CA
Sukesh Sukumaran, MBBS, MD, DPMR; Children’s Hospital of Los
Angeles; Los Angeles, CA
Session Overview:
Uveitis is the third leading cause of preventable, irreversible
blindness in the developed world. Frequently, localized therapy
is not sufficient to treat these complicated inflammatory
processes. With the availability of chemotherapy and biologic
treatments for these conditions, ophthalmologists are
increasingly consulting with rheumatologists for input on
systemic therapy and management. Therefore the rheumatology
community must become familiar with the etiology and effects
of treatment in inflammatory eye diseases.
Upon completion of this session, participants should be able to:
• use a case study model to analyze and apply uveitis principles
in the clinical context
• review the etiology and common subtypes of uveitis
• define the role of the rheumatologist in the uveitis treatment
team
• review the traditional pharmacologic treatment
recommendations for uveitis and compare them to advanced
treatments with biologics
B310
Physical Activity: The Arthritis Pain Reliever – The
Revised Centers for Disease Control and Prevention
Health Communications Campaign c/r PM PS
Moderator: Gail C. Davis, RN, EdD; Texas Woman’s University;
Denton, TX
Speaker: Teresa J. Brady, PhD; Center for Disease Control;
Atlanta, GA
Session Overview:
Enticing people with arthritis to increase their physical activity
is a priority for both clinicians and public health practitioners.
However, our collective efforts have been marginally effective
as 44 percent of people with arthritis report no leisure time
activity. Describing the required activity levels in concrete
understandable terms, addressing the unique concerns of
people with arthritis, and highlighting the most desired potential
benefits of physical activity can all help address this gap. In 2010
the Centers for Disease Control and Prevention Arthritis Program
released a revised version of the health communications
campaign Physical Activity, The Arthritis Pain Reliever. The
campaign was based on research findings related to physical
activity attitudes, perceptions, and preferences among people
with arthritis.
Upon completion of this session, participants should be able to:
• describe key learnings derived from qualitative audience
research about physical activity conducted among people with
arthritis
• discuss how these key learnings can be utilized in clinical
practice
• identify key elements of the revised Physical Activity: The
Arthritis Pain Reliever health communications campaign
• develop individual physical activity-related counseling and
instruction plans
InnoVAtion Theater
12:15 - 1:00 pm
Halls A1 & A2 (Booth #555)
The following non-CME activity has been planned and will be
implemented in accordance with the requirements of the FDA
and applicable standards of the PhRMA Code on Interactions
with Healthcare Professionals by Centocor Ortho Biotech Inc.
Please visit the Centocor Ortho Biotech Inc. exhibit booth for
more information or see page 292. Seating and boxed lunches
are subject to availability.
Choices and Challenges in Managing Psoriatic
Arthritis
ARHP Special Sessions
12:30 - 1:30 pm
The ARHP is offering informal networking opportunities for
rheumatology health professional disciplines and students. These
networking opportunities, led by facilitators, will allow open
discussion and interaction with fellow attendees. Bring your
lunch and join a group.
These sessions are not eligible for CME credit.
B310
ARHP Networking for Georgia Health Professionals
and Physicians
Facilitator: Joyce P. Carlone, MN, RN, FNP-BC; Emory University;
Atlanta, GA
B309
ARHP Pediatrics Networking
Facilitator: Karla B. Jones, MS, RN, CPNP; Nationwide Children’s
Hospital; Columbus, OH
B311
ARHP Research Coordinators Networking
Facilitators: Donah Z. Crawford, BS, MA; The Arthritis Group;
Philadelphia, PA
Lisa M. Kastanek, RN, CCRC; Physician Research Collaboration;
Lincoln, NE
ACR Meet the Professor Sessions
12:45 - 2:15 pm
Admission to each Meet the Professor session requires a
separate registration and ticket. To verify which session you
registered for, check to make sure the registration code on your
ticket matches the code listed below in parentheses.
B207
Adult Inflammatory Myopathy (011)
Speaker: Mary E. Cronin, MD; Medical College of Wisconsin;
Milwaukee, WI
2010 Program Book 35
monday